Safety
SAEs, hypogammaglobulinaemia
ADVERSE EVENT, HYPOGAMMAGLOBULINAEMIA
Sixty-nine SAEs occurred in 37 (44%) patients in the rituximab and 105 in 48 (56%) in the azathioprine groups (
Adverse events according to treatment regimen in the RITAZAREM trialMultivariable model of predictors for the development of hypogammaglobulinaemia in the RITAZAREM trialGlucocorticoid induction regimen: 1A=1 mg/kg/day starting dose; 1B=0.5 mg/kg/day starting dose.*Baseline plasma IgG level was centred around the mean value (9.56). The intercept gives an estimate of the absolute odds for a patient with the mean value of baseline IgG, and the reference levels of the other binary predictors.MPO, myeloperoxidase; PR3, proteinase 3.